These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 7693820)
1. Immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. Groome N; O'Brien M J Immunol Methods; 1993 Oct; 165(2):167-76. PubMed ID: 7693820 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal and polyclonal antibodies reactive with the 1-32 amino terminal sequence of the alpha subunit of human 32K inhibin. Groome N; Hancock J; Betteridge A; Lawrence M; Craven R Hybridoma; 1990 Feb; 9(1):31-42. PubMed ID: 1690174 [TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive two-site assays for inhibin-A and activin-A using monoclonal antibodies raised to synthetic peptides. Groome N J Immunol Methods; 1991 Dec; 145(1-2):65-9. PubMed ID: 1765667 [TBL] [Abstract][Full Text] [Related]
4. Development of a two-site immunoradiometric assay for dimeric inhibin using antibodies against chemically synthesized fragments of the alpha and beta subunit. Knight PG; Groome N; Beard AJ J Endocrinol; 1991 May; 129(2):R9-12. PubMed ID: 2040852 [TBL] [Abstract][Full Text] [Related]
5. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. Knight PG; Muttukrishna S; Groome NP J Endocrinol; 1996 Feb; 148(2):267-79. PubMed ID: 8699141 [TBL] [Abstract][Full Text] [Related]
6. Measurement of dimeric inhibin B throughout the human menstrual cycle. Groome NP; Illingworth PJ; O'Brien M; Pai R; Rodger FE; Mather JP; McNeilly AS J Clin Endocrinol Metab; 1996 Apr; 81(4):1401-5. PubMed ID: 8636341 [TBL] [Abstract][Full Text] [Related]
7. Development of a specific and sensitive two-site enzyme-linked immunosorbent assay for measurement of inhibin-A in serum. Baly DL; Allison DE; Krummen LA; Woodruff TK; Soules MR; Chen SA; Fendly BM; Bald LN; Mathers JP; Lucas C Endocrinology; 1993 May; 132(5):2099-108. PubMed ID: 8477659 [TBL] [Abstract][Full Text] [Related]
8. Preparation of monoclonal antibodies to the beta A subunit of ovarian inhibin using a synthetic peptide immunogen. Groome N; Lawrence M Hybridoma; 1991 Apr; 10(2):309-16. PubMed ID: 1714879 [TBL] [Abstract][Full Text] [Related]
9. Development of an inhibin alpha subunit ELISA with broad specificity. Robertson DM; Stephenson T; Cahir N; Tsigos A; Pruysers E; Stanton PG; Groome N; Thirunavukarasu P Mol Cell Endocrinol; 2001 Jun; 180(1-2):79-86. PubMed ID: 11451575 [TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies. Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252 [TBL] [Abstract][Full Text] [Related]
11. Characterization of inhibin forms and their measurement by an inhibin alpha-subunit ELISA in serum from postmenopausal women with ovarian cancer. Robertson DM; Stephenson T; Pruysers E; McCloud P; Tsigos A; Groome N; Mamers P; Burger HG J Clin Endocrinol Metab; 2002 Feb; 87(2):816-24. PubMed ID: 11836327 [TBL] [Abstract][Full Text] [Related]
12. A two-site enzyme-linked immunosorbent assay for inhibin. Betteridge A; Craven RP Biol Reprod; 1991 Nov; 45(5):748-54. PubMed ID: 1721843 [TBL] [Abstract][Full Text] [Related]
13. Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. Lambert-Messerlian GM; Hall JE; Sluss PM; Taylor AE; Martin KA; Groome NP; Crowley WF; Schneyer AL J Clin Endocrinol Metab; 1994 Jul; 79(1):45-50. PubMed ID: 8027251 [TBL] [Abstract][Full Text] [Related]
14. Development of a new antibody to the human inhibin/activin betaB subunit and its application to improved inhibin B ELISAs. Ludlow H; Muttukrishna S; Hyvönen M; Groome NP J Immunol Methods; 2008 Jan; 329(1-2):102-11. PubMed ID: 17991484 [TBL] [Abstract][Full Text] [Related]
15. Biological and immunological characterization of inhibin forms in human plasma. Robertson D; Burger HG; Sullivan J; Cahir N; Groome N; Poncelet E; Franchimont P; Woodruff T; Mather JP J Clin Endocrinol Metab; 1996 Feb; 81(2):669-76. PubMed ID: 8636287 [TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of high molecular weight forms of inhibin from bovine follicular fluid. Sugino K; Nakamura T; Takio K; Miyamoto K; Hasegawa Y; Igarashi M; Titani K; Sugino H Endocrinology; 1992 Feb; 130(2):789-96. PubMed ID: 1733725 [TBL] [Abstract][Full Text] [Related]
17. Quantification of inhibin pro-alpha C-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay. Groome NP; Illingworth PJ; O'Brien M; Priddle J; Weaver K; McNeilly AS J Clin Endocrinol Metab; 1995 Oct; 80(10):2926-32. PubMed ID: 7559876 [TBL] [Abstract][Full Text] [Related]
18. Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidized (Met O) inhibin. Knight PG; Muttukrishna S J Endocrinol; 1994 Jun; 141(3):417-25. PubMed ID: 8071641 [TBL] [Abstract][Full Text] [Related]
19. Development of a two-site solid-phase immunochemiluminescent assay for measurement of dimeric inhibin-A in human serum and other biological fluids. McConnell DS; Padmanabhan V; Pollak TB; Groome NP; Ireland JJ; Midgley AR Clin Chem; 1996 Aug; 42(8 Pt 1):1159-67. PubMed ID: 8697571 [TBL] [Abstract][Full Text] [Related]
20. Inhibin as a marker for ovarian cancer. Cooke I; O'Brien M; Charnock FM; Groome N; Ganesan TS Br J Cancer; 1995 May; 71(5):1046-50. PubMed ID: 7734297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]